The cell separation market size has grown rapidly in recent years. It will grow from $13.29 billion in 2024 to $15.47 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to introduction of traditional techniques, emergence of flow cytometry, magnetic cell separation, development of gradient separation, early adoption in biomedical research.
The cell separation market size is expected to see rapid growth in the next few years. It will grow to $30.24 billion in 2029 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to integration of artificial intelligence (ai) and data analytics, investments in research and development, increasing demand in biopharmaceuticals, rise in stem cell research. Major trends in the forecast period include microfluidic technologies, emergence of novel separation technique, growing demand in biotechnology and research, focus on precision medicine, automation and high-throughput processing.
The growth of the cell separation market is significantly influenced by the increasing number of patients suffering from cancer. Cancer is a severe disorder characterized by uncontrolled and rapid cell reproduction, leading to abnormal growth. In cancer treatment, cell separation plays a crucial role in isolating cancer tumor cells from normal cells for examination and treatment. For example, in September 2022, Cancer Australia reported an estimated 2,572 new cases of stomach cancer in Australia for the year. The rising incidence of cancer, such as stomach cancer, is expected to drive the demand for cell separation techniques, contributing to the growth of the market.
The cell separation market is anticipated to experience growth due to the increasing shift towards personalized medicine. Personalized medicine, also known as precision medicine, involves tailoring medical treatment to individual variations in patients' genes, environments, and lifestyles. This approach is likely to enhance cell separation procedures, allowing for more precise and individualized applications in biomedical and therapeutic fields. According to the Personalized Medicine Coalition's data from February 2023, personalized medicines accounted for 34% of new drugs approved by the US Food and Drug Administration in 2022. This trend indicates a growing reliance on personalized medicine, driving the demand for advanced cell separation techniques to support individualized medical approaches.
Technological advancements represent a key trend in the cell separation market. Major companies are investing in the development of innovative cell separation technologies to increase throughput and optimize processes, gaining a competitive advantage. For instance, Akadeum Life Sciences, a US-based biotechnology company, launched the Microbubble Leukopak Human T Cell Isolation Kit in September 2022. This kit utilizes buoyancy-based cell separation technology, combining microbubbles with a Buoyancy Activated Cell Sorting (BACSTM) Separation Tube. The innovative kit allows scientists to process larger volumes of leukopaks in significantly less time compared to traditional procedures, improving productivity and operational efficiency. The emphasis on technological advancements is expected to further propel the growth of the cell separation market.
Leading companies in the cell separation market are adopting a strategic partnership approach to enhance their offerings, particularly in the supply of reagent kits for cell separation. This strategic collaboration involves leveraging the strengths and resources of each partner to achieve mutual benefits and success. An illustrative example of this approach is the partnership announced in April 2022 between Applied Cells Inc., a US-based research and pharmaceutical manufacturing company, and STEMCELL Technologies Canada Inc., a Canadian biotechnological company. Applied Cells Inc. and STEMCELL Technologies are collaborating to provide a high-performance cell separation solution by combining Applied Cells' MARS technology with STEMCELL's EasySep immunomagnetic cell separation kits. This partnership aims to assist researchers globally by automating and improving the efficiency of separating high-quality cells from various sample types, including whole blood, bone marrow, apheresis products, and dissociated tissue. The integration of Applied Cells' MARS platform with STEMCELL Technologies' cell division reagents is positioned as a next-generation solution to address evolving cell separation requirements in the research industry.
In July 2022, Bio-Techne Corporation, a prominent US-based biotechnology company, adopted a strategic approach by acquiring Namocell Inc., a US-based biotechnology company, for an undisclosed amount. The acquisition includes innovative single-cell sorting and dispensing platforms, enhancing Bio-Techne Corporation's offerings in the cell separation market. Namocell's technology empowers single-cell research and therapeutics development, aligning with Bio-Techne Corporation's commitment to providing advanced solutions in the field.
Major companies operating in the cell separation market include Becton Dickinson and Company, Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Terumo Corporation, Miltenyi Biotec GmbH, Beckman Coulter Inc., STEMCELL Technologies Inc., PluriSelect Life Science UG and Co. KG, GE HealthCare Technologies Inc., Philips Healthcare Informatics Inc., 10X Genomics Inc., Carl Zeiss AG, Life Technologies Inc., Danaher Corporation, Agilent Technologies Inc., Corning Incorporated, F. Hoffmann-La Roche Ltd., Alfa Laval AB, Sartorius AG, Bio-Techne Corp., PerkinElmer Inc., Invent Biotechnologies Inc., Takara Bio Inc., Lonza Group Ltd., Promega Corporation, MagBio Genomics, Akadeum Life Sciences Inc., MiCareo Inc., Proteintech Group Inc., QIAGEN NV.
North America was the largest region in the cell separation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cell separation market report during the forecast period. The regions covered in the cell separation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell separation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Cell separation is a technique employed to extract specific cell types from a diverse mixture of cells, allowing for the identification, isolation, and manipulation of particular cells for research, diagnostic, and therapeutic purposes.
The primary categories of cells used in cell separation processes include human and animal cells. Human cells represent the basic structural and functional units of the human body. Various methodologies are utilized for cell separation, including gradient centrifugation, surface marker separation, fluorescence-activated cell sorting, and magnetic cell sorting. Products associated with cell separation encompass consumables and instruments, facilitating applications such as biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics, and therapeutic development.
The cell separation market research report is one of a series of new reports that provides cell separation market statistics, including cell separation industry global market size, regional shares, competitors with a cell separation market share, detailed cell separation market segments, market trends and opportunities, and any further data you may need to thrive in the cell separation industry. This cell separation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cell separation market consists of revenues earned by entities by providing immunomagnetic cell separation, immunodensity cell separation, microfluidic cell separation, and sedimentation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell separation market also includes sales of kits, buffers, strainers, separation devices, and accessories used in providing cell separation services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The cell separation market size is expected to see rapid growth in the next few years. It will grow to $30.24 billion in 2029 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to integration of artificial intelligence (ai) and data analytics, investments in research and development, increasing demand in biopharmaceuticals, rise in stem cell research. Major trends in the forecast period include microfluidic technologies, emergence of novel separation technique, growing demand in biotechnology and research, focus on precision medicine, automation and high-throughput processing.
The growth of the cell separation market is significantly influenced by the increasing number of patients suffering from cancer. Cancer is a severe disorder characterized by uncontrolled and rapid cell reproduction, leading to abnormal growth. In cancer treatment, cell separation plays a crucial role in isolating cancer tumor cells from normal cells for examination and treatment. For example, in September 2022, Cancer Australia reported an estimated 2,572 new cases of stomach cancer in Australia for the year. The rising incidence of cancer, such as stomach cancer, is expected to drive the demand for cell separation techniques, contributing to the growth of the market.
The cell separation market is anticipated to experience growth due to the increasing shift towards personalized medicine. Personalized medicine, also known as precision medicine, involves tailoring medical treatment to individual variations in patients' genes, environments, and lifestyles. This approach is likely to enhance cell separation procedures, allowing for more precise and individualized applications in biomedical and therapeutic fields. According to the Personalized Medicine Coalition's data from February 2023, personalized medicines accounted for 34% of new drugs approved by the US Food and Drug Administration in 2022. This trend indicates a growing reliance on personalized medicine, driving the demand for advanced cell separation techniques to support individualized medical approaches.
Technological advancements represent a key trend in the cell separation market. Major companies are investing in the development of innovative cell separation technologies to increase throughput and optimize processes, gaining a competitive advantage. For instance, Akadeum Life Sciences, a US-based biotechnology company, launched the Microbubble Leukopak Human T Cell Isolation Kit in September 2022. This kit utilizes buoyancy-based cell separation technology, combining microbubbles with a Buoyancy Activated Cell Sorting (BACSTM) Separation Tube. The innovative kit allows scientists to process larger volumes of leukopaks in significantly less time compared to traditional procedures, improving productivity and operational efficiency. The emphasis on technological advancements is expected to further propel the growth of the cell separation market.
Leading companies in the cell separation market are adopting a strategic partnership approach to enhance their offerings, particularly in the supply of reagent kits for cell separation. This strategic collaboration involves leveraging the strengths and resources of each partner to achieve mutual benefits and success. An illustrative example of this approach is the partnership announced in April 2022 between Applied Cells Inc., a US-based research and pharmaceutical manufacturing company, and STEMCELL Technologies Canada Inc., a Canadian biotechnological company. Applied Cells Inc. and STEMCELL Technologies are collaborating to provide a high-performance cell separation solution by combining Applied Cells' MARS technology with STEMCELL's EasySep immunomagnetic cell separation kits. This partnership aims to assist researchers globally by automating and improving the efficiency of separating high-quality cells from various sample types, including whole blood, bone marrow, apheresis products, and dissociated tissue. The integration of Applied Cells' MARS platform with STEMCELL Technologies' cell division reagents is positioned as a next-generation solution to address evolving cell separation requirements in the research industry.
In July 2022, Bio-Techne Corporation, a prominent US-based biotechnology company, adopted a strategic approach by acquiring Namocell Inc., a US-based biotechnology company, for an undisclosed amount. The acquisition includes innovative single-cell sorting and dispensing platforms, enhancing Bio-Techne Corporation's offerings in the cell separation market. Namocell's technology empowers single-cell research and therapeutics development, aligning with Bio-Techne Corporation's commitment to providing advanced solutions in the field.
Major companies operating in the cell separation market include Becton Dickinson and Company, Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Terumo Corporation, Miltenyi Biotec GmbH, Beckman Coulter Inc., STEMCELL Technologies Inc., PluriSelect Life Science UG and Co. KG, GE HealthCare Technologies Inc., Philips Healthcare Informatics Inc., 10X Genomics Inc., Carl Zeiss AG, Life Technologies Inc., Danaher Corporation, Agilent Technologies Inc., Corning Incorporated, F. Hoffmann-La Roche Ltd., Alfa Laval AB, Sartorius AG, Bio-Techne Corp., PerkinElmer Inc., Invent Biotechnologies Inc., Takara Bio Inc., Lonza Group Ltd., Promega Corporation, MagBio Genomics, Akadeum Life Sciences Inc., MiCareo Inc., Proteintech Group Inc., QIAGEN NV.
North America was the largest region in the cell separation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cell separation market report during the forecast period. The regions covered in the cell separation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell separation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Cell separation is a technique employed to extract specific cell types from a diverse mixture of cells, allowing for the identification, isolation, and manipulation of particular cells for research, diagnostic, and therapeutic purposes.
The primary categories of cells used in cell separation processes include human and animal cells. Human cells represent the basic structural and functional units of the human body. Various methodologies are utilized for cell separation, including gradient centrifugation, surface marker separation, fluorescence-activated cell sorting, and magnetic cell sorting. Products associated with cell separation encompass consumables and instruments, facilitating applications such as biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics, and therapeutic development.
The cell separation market research report is one of a series of new reports that provides cell separation market statistics, including cell separation industry global market size, regional shares, competitors with a cell separation market share, detailed cell separation market segments, market trends and opportunities, and any further data you may need to thrive in the cell separation industry. This cell separation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cell separation market consists of revenues earned by entities by providing immunomagnetic cell separation, immunodensity cell separation, microfluidic cell separation, and sedimentation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell separation market also includes sales of kits, buffers, strainers, separation devices, and accessories used in providing cell separation services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Cell Separation Market Characteristics3. Cell Separation Market Trends and Strategies4. Cell Separation Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Cell Separation Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Cell Separation Market34. Recent Developments in the Cell Separation Market
5. Global Cell Separation Growth Analysis and Strategic Analysis Framework
6. Cell Separation Market Segmentation
7. Cell Separation Market Regional and Country Analysis
8. Asia-Pacific Cell Separation Market
9. China Cell Separation Market
10. India Cell Separation Market
11. Japan Cell Separation Market
12. Australia Cell Separation Market
13. Indonesia Cell Separation Market
14. South Korea Cell Separation Market
15. Western Europe Cell Separation Market
16. UK Cell Separation Market
17. Germany Cell Separation Market
18. France Cell Separation Market
19. Italy Cell Separation Market
20. Spain Cell Separation Market
21. Eastern Europe Cell Separation Market
22. Russia Cell Separation Market
23. North America Cell Separation Market
24. USA Cell Separation Market
25. Canada Cell Separation Market
26. South America Cell Separation Market
27. Brazil Cell Separation Market
28. Middle East Cell Separation Market
29. Africa Cell Separation Market
30. Cell Separation Market Competitive Landscape and Company Profiles
31. Cell Separation Market Other Major and Innovative Companies
35. Cell Separation Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Cell Separation Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on cell separation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cell separation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell separation market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- the market characteristics section of the report defines and explains the market.
- the market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- the forecasts are made after considering the major factors currently impacting the market. These include:
- the forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- the regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- the competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- the trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Cell Type: Human Cells; Animal Cells2) by Type: Gradient Centrifugation; Surface Markers Separation; Fluorescence Activated Cell Sorting; Magnetic Cell Sorting
3) by Product: Consumables; Instruments
4) by Application: Biomolecule Isolation; Cancer Research; Stem Cell Research; Tissue Regeneration; in Vitro Diagnostics; Therapeutics
Subsegments:
1) by Human Cells: Blood Cells; Stem Cells; Tumor Cells2) by Animal Cells: Mammalian Cells; Avian Cells; Insect Cells
Key Companies Mentioned: Becton Dickinson and Company; Merck KGaA; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; Terumo Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Cell Separation market report include:- Becton Dickinson and Company
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Terumo Corporation
- Miltenyi Biotec GmbH
- Beckman Coulter Inc.
- STEMCELL Technologies Inc.
- PluriSelect Life Science UG and Co. KG
- GE HealthCare Technologies Inc.
- Philips Healthcare Informatics Inc.
- 10X Genomics Inc.
- Carl Zeiss AG
- Life Technologies Inc.
- Danaher Corporation
- Agilent Technologies Inc.
- Corning Incorporated
- F. Hoffmann-La Roche Ltd.
- Alfa Laval AB
- Sartorius AG
- Bio-Techne Corp.
- PerkinElmer Inc.
- Invent Biotechnologies Inc.
- Takara Bio Inc.
- Lonza Group Ltd.
- Promega Corporation
- MagBio Genomics
- Akadeum Life Sciences Inc.
- MiCareo Inc.
- Proteintech Group Inc.
- QIAGEN NV
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 15.47 Billion |
| Forecasted Market Value ( USD | $ 30.24 Billion |
| Compound Annual Growth Rate | 18.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 32 |
